Our novel anti-biofilm strategy aims to address the burden of biofilm-mediated inflammation and progressive lung function. Read more on how we're working to combat chronic respiratory conditions.

Meet our team: a strategically focused group of experts with deep therapeutic and vaccine development expertise.

In the News